• Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

Medical Cannabis: A Survey for Primary Care Physicians


Calling all primary care physicians: we are conducting a survey of your opinions about prescribing medical marijuana and invite you to participate.

Twenty states and Washington, DC, have now legalized the use of medical cannabis. Yet there is still no evidence for its use in for most disorders. Some evidence suggests that cannabis helps alleviate nausea (eg, in patients receiving chemotherapy), muscle spasticity in spinal cord injuries, and some neuropathic pain.

Marijuana is still classified as a Schedule I drug (in the same category as LSD, PCP, and methamphetamines), while cocaine, for example, is classified as a Schedule II drug. This limits the ability of researchers to explore potential medical uses for marijuana.

Given the paucity of evidence for the uses of medicinal cannabis-- and still very unclear and conflicting local and federal laws-- we are curious to learn what primary care physicians think about prescribing medical cannabis. We invite you to complete a brief survey to let us know.

We will later review and share the results of that survey.
Please click here to take the short survey.

Related Videos
"Vaccination is More of a Marathon than a Sprint"
Vaccines are for Kids, Booster Fatigue, and Other Obstacles to Adult Immunization
Related Content
© 2024 MJH Life Sciences

All rights reserved.